Disorders of hair loss are commonly encountered by hair stylists, who are in a unique position to identify early signs and symptoms. The goals of this study were to assess hair stylists’ knowledge of and propensity to refer patients with scarring alopecias. One-hundred-eighteen stylists completed surveys to this effect. The majority of respondents (66.1%) stated that they had been asked by clients to evaluate for hair loss, whereas approximately half reported routinely referring clients with hair loss to a dermatologist. Although knowledge of alopecia varied, the vast majority indicated they would be willing to undergo further training in identifying hair loss disorders and would be willing to discuss this information with clients. These results demonstrate that hairdressers frequently interact with patients suffering from hair loss and that many are receptive to receiving additional training to ensure proper identification and prompt referral.
Psoriatic arthritis is commonly encountered in psoriasis patients. Its presentation varies and has several subtypes. Psoriatic arthritis should be differentiated from other forms of arthritis. The clinician must differentiate between the other potential various arthropathies that may be seen in patients with psoriasis. After the diagnosis is made, treatment can be tailored to the individual and his or her co-morbidities. There are several therapeutic options, ranging from nonsteroidal anti-inflammatory drugs to biologic drugs. In order to provide optimal care for the patient, the clinician should become versed in various diagnostic and therapeutic modalities of psoriatic arthritis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.